References
- Liu A, McLellan K, Reinholt B. How medical-device manufacturers can transform marketing and sales capabilities. 2015 cited 2022 Feb 5]; Available from 2022 Feb 5: https://www.mckinsey.com/industries/life-sciences/our-insights/how-medical-device-manufacturers-can-transform-marketing-and-sales-capabilities
- KPMG China. Medical devices 2030: making a power play to avoid the commodity trap. China: KPMG Advisory (China) Limited; 2018. https://assets.kpmg/content/dam/kpmg/cn/pdf/en/2018/04/medical-devices-2030.pdf cited 2022 Jan 31]; Available from 2022 Jan 31
- Ratassepp T, Shagandina A, Turunen J, et al. Counseling in the use of personal medical devices and drug-delivery products—A traditional or extended community pharmacy service. Farmacia. 2015;63:388–393.
- Rezaee R, Noori J, Mahmoudi SM, et al. Outcomes of public procurement in technology development of medical devices: a narrative review. Int Arch Health Sci. 2020;7:113–118. doi:10.4103/iahs.iahs_75_19.
- WHO. Medical devices: managing the mismatch: an outcome of the priority medical devices project. World Health Org. 2010.
- Beswick DM, Kaushik A, Beinart D, et al. Biomedical device innovation methodology: applications in biophotonics. J Biomed Opt. 2017;23:021102. doi:10.1117/1.JBO.23.2.021102.
- Maresova P, Hajek L, Krejcar O, et al. New regulations on medical devices in Europe: are they an opportunity for growth? Adm Sci. 2020;10:16. doi:10.3390/admsci10010016.
- Jakovljevic M, Wu W, Merrick J, et al. Asian innovation in pharmaceutical and medical device industry–beyond tomorrow. J Med Econ. 2021;24(sup1):42–50. doi:10.1080/13696998.2021.2013675.
- Wang Y, Rattanavipapong W, Teerawattananon Y. Using health technology assessment to set priority, inform target product profiles, and design clinical study for health innovation. Technol Forecasting Social Change. 2021;172:121000.
- Joore M, Grimm S, Boonen A, et al. Health technology assessment: a framework. RMD Open. 2020;6:e001289. doi:10.1136/rmdopen-2020-001289.
- Jakovljevic M, Liu Y, Cerda A, et al. The Global South political economy of health financing and spending landscape–history and presence. J Med Econ. 2021;24:25–33. doi:10.1080/13696998.2021.2007691.
- BIDA. Healthcare & medical device industries. 2021 cited 2022 Feb 5]; Available from 2022 Feb 5: https://bida.gov.bd/storage/app/uploads/public/616/6c3/2de/6166c32dec22c700971227.pdf
- Thompson N. Rapid growth in China’s medical device industry. 2021 Medical Device Network cited 2022 Feb 8]. Accessed from 2022 Feb 8 https://www.medicaldevice-network.com/sponsored/rapid-growth-in-chinas-medical-device-industry/
- IBEF. Medical devices industry in India. 2021 India Brand Equity Foundation. cited 2022 Feb 20]; Available from 2022 Feb 20: https://www.ibef.org/industry/medical-devices.aspx
- Magia2Japan. Study on the Japanese medtech industry. MAGIA project team 2021 cited 2022 Feb 6]; Available from 2022 Feb 6: https://www.magia2market.com/wp-content/uploads/2021/04/MEDTECH-JAPANESE-MARKET-STUDY_Copyright.pdf
- Andaman Medical. Singapore’s medical device market. Andaman Medical Privacy Policy. 2022 cited 2022 Feb 7] Available from 2022 Feb 7: https://andamanmed.com/target-markets/Singapore
- Kurrer C. Medicines and medical devices: fact sheets on the European Union-2021. 2021 cited 2022 Feb 8]; Available from 2022 Feb 8: https://www.europarl.europa.eu/ftu/pdf/en/FTU_2.2.5.pdf
- Parvizi N, Woods K. Regulation of medicines and medical devices: contrasts and similarities. Clin Med. 2014;14:6–12.
- Clinical Trials Arena. Outlining the key differences between medical device and drug trials. 2018 cited 2022 Feb 8]; Available from 2022 Feb 8: https://www.clinicaltrialsarena.com/news/
- UNESCAP. List of countries in the Asia-Pacific region and subregions. 2020 cited 2022 Feb 8]; Available from: https://data.unescap.org/dataviz/methodology/list-of-countries-in-the-asia-pacific-region-and-subregions.html
- Kim D, Ryu GH, Shin K, et al. What are the success factors for a partnership with global medical device companies? Evidence from Korea. J Open Innov Technol Mark Complex. 2021;7:237. doi:10.3390/joitmc7040237.
- Kale D. Mind the gap: investigating the role of collective action in the evolution of Indian medical device regulation. Technol Soc. 2019;59:1–13. doi:10.1016/j.techsoc.2019.03.004.
- Shah SGS, Robinson I, AlShawi S. Developing medical device technologies from users’ perspectives: a theoretical framework for involving users in the development process. Int J Technol Assess Health Care. 2009;25:514–521. doi:10.1017/S0266462309990328.
- Guerra-Bretaña RM, Flórez-Rendón AL. Impact of regulations on innovation in the field of medical devices. Res Biomed Eng. 2018;34:356–367. doi:10.1590/2446-4740.180054.
- EUPATI. Health technology assessment process: fundamentals. European Patients’ Academy on Therapeutic Inovation. 2022 cited 2022 Feb 8]; Available from https://toolbox.eupati.eu/resources/health-technology-assessment-process-fundamentals/?print=pdf
- Marešová P, Klímová B, Honegr J, et al. Medical device development process, and associated risks and legislative aspects-systematic review. Front Public Health. 2020:308. doi:10.3389/fpubh.2020.00308.
- Twi Ltd. What is the medical device development process? (includes stages). TWI Ltd (Head Office), Cambridge: UK 2021 cited 2022 Jan 31]; Available from: https://www.twi-global.com/technical-knowledge/faqs/what-is-the-medical-device-development-process.
- WHO. Medical device regulations: global overview and guiding principles. Geneva: Switzerland: World Health Organization Department of Blood Safety and Clinical Technology; 2003. p. 1–43.
- Jakovljevic M, Jakab M, Gerdtham U, et al. Comparative financing analysis and political economy of noncommunicable diseases. J Med Econ. 2019;22:722–727. doi:10.1080/13696998.2019.1600523.
- Waninger MS, Whirley RG, Smith LJ, et al. Manufacturer evaluations of endograft modifications. J Vasc Surg. 2013;57:826–828. doi:10.1016/j.jvs.2012.12.027.
- Gupta SK. Medical device regulations: a current perspective. J Young Pharm. 2016;8:6–11.
- Sarvestani AS, Sienko KH. Medical device landscape for communicable and noncommunicable diseases in low-income countries. Global Health. 2018;14:65. doi:10.1186/s12992-018-0355-8.
- Garay OU, Elorrio EG, Rodríguez V, et al. Single-use devices in Argentina: cost comparison analysis of a “re-use” versus a “single-use” policy for trocars, endocutters, linear cutters, and harmonic scalpels. Value Health Reg Issues. 2017;14C:89–95. doi:10.1016/j.vhri.2017.04.005.
- Jakovljevic M, Timofeyev Y, Ranabhat CL, et al. Real GDP growth rates and healthcare spending–comparison between the G7 and the EM7 countries. Global Health. 2020;16:64. doi:10.1186/s12992-020-00590-3.
- Bouchet A, Boucher J, Schutzbach K, et al. Which strategy for using medical and community masks? A prospective analysis of their environmental impact. BMJ Open. 2021;11:e049690. doi:10.1136/bmjopen-2021-049690.
- Wizemann T. Public health effectiveness of the FDA 510(k) clearance process: balancing patient safety and innovation: workshop report. In: Committee on the Public Health Effectiveness of the FDA 510(k). USA: Clearance Process and Institute of Medicine; 2010. p. 1–61.
- IMDRF. Essential Principles of Safety and Performance of Medical Devices and IVD Medical Devices Introduction and Consideration. Int Med Device Regulators Forum (IMDRF). 2018;1–32. Good Regulatory Review Practices Group.
- GMTA. The need for advancing global convergence of medical technology regulation. Global Medical Technology Alliance; 2018. 1–4. cited 2021 Oct 1]; Available from 2021 Oct 1: http://www.globalmedicaltechnologyalliance.org/papers/GMTA%20Global%20Harmonization%20of%20Medical%20Technology%20Regulations.pdf.
- Kaushik A, Saini KS, Anil B, et al. Harmonized medical device regulation: need, challenges, and risks of not harmonizing the regulation in Asia. J Young Pharm. 2010;2:101–106. doi:10.4103/0975-1483.62221.
- Kaplan AV, Williams DO. Medical device regulatory landscape: the imperative of finding balance. Circ Cardiovasc Interv. 2012;5:2–5. doi:10.1161/CIRCINTERVENTIONS.112.968560.
- George B. Registration of medical devices. Perspect Clin Res. 2010;1:90–93.
- Jakovljevic MB, Nakazono S, Ogura S. Contemporary generic market in Japan–key conditions to successful evolution. Expert Rev Pharmacoecon Outcomes Res. 2014;14:181–194. doi:10.1586/14737167.2014.881254.
- Jakovljevic M. Therapeutic innovations: the future of health economics and outcomes research–increasing role of the Asia-Pacific. J Med Econ. 2021;24:1–3. doi:10.1080/13696998.2021.2014164.
- Jakovljevic M, Sugahara T, Timofeyev Y, et al. Predictors of (in) efficiencies of healthcare expenditure among the leading asian economies–comparison of OECD and non-OECD nations. Risk Manag Healthc Policy. 2020;13:2261–2280. doi:10.2147/RMHP.S266386.
- Lim JCW. Strengthening health products regulatory systems to enhance access to quality health products in the Asia-Pacific. Ther Innov Regul Sci. 2018;52:1–4. doi:10.1177/2168479018769285.